| Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium IG McKeith, BF Boeve, DW Dickson, G Halliday, JP Taylor, D Weintraub, ... Neurology 89 (1), 88-100, 2017 | 3372 | 2017 |
| Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ... Nature genetics 51 (3), 414-430, 2019 | 2180 | 2019 |
| Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature PT Nelson, I Alafuzoff, EH Bigio, C Bouras, H Braak, NJ Cairns, ... Journal of Neuropathology & Experimental Neurology 71 (5), 362-381, 2012 | 2134 | 2012 |
| The Parkinson progression marker initiative (PPMI) K Marek, D Jennings, S Lasch, A Siderowf, C Tanner, T Simuni, C Coffey, ... Progress in neurobiology 95 (4), 629-635, 2011 | 1490 | 2011 |
| Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial S Craft, LD Baker, TJ Montine, S Minoshima, GS Watson, A Claxton, ... Archives of neurology 69 (1), 29-38, 2012 | 1377 | 2012 |
| Analysis of shared heritability in common disorders of the brain Brainstorm Consortium, V Anttila, B Bulik-Sullivan, HK Finucane, ... Science 360 (6395), eaap8757, 2018 | 1367 | 2018 |
| Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria DW Dickson, H Braak, JE Duda, C Duyckaerts, T Gasser, GM Halliday, ... The Lancet Neurology 8 (12), 1150-1157, 2009 | 1110 | 2009 |
| Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ... Nature genetics 49 (9), 1373-1384, 2017 | 901 | 2017 |
| TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis VM Van Deerlin, JB Leverenz, LM Bekris, TD Bird, W Yuan, LB Elman, ... The Lancet Neurology 7 (5), 409-416, 2008 | 862 | 2008 |
| DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease Z Hong, M Shi, KA Chung, JF Quinn, ER Peskind, D Galasko, J Jankovic, ... Brain 133 (3), 713-726, 2010 | 725 | 2010 |
| TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models TR Jay, CM Miller, PJ Cheng, LC Graham, S Bemiller, ML Broihier, G Xu, ... Journal of Experimental Medicine 212 (3), 287-295, 2015 | 691 | 2015 |
| DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers CF Lippa, JE Duda, M Grossman, HI Hurtig, D Aarsland, BF Boeve, ... Neurology 68 (11), 812-819, 2007 | 680 | 2007 |
| Neuropathologic substrates of Parkinson disease dementia DJ Irwin, MT White, JB Toledo, SX Xie, JL Robinson, V Van Deerlin, ... Annals of neurology 72 (4), 587-598, 2012 | 552 | 2012 |
| Clinico‐neuropathological correlation of Alzheimer's disease in a community‐based case series A Lim, D Tsuang, W Kukull, D Nochlin, J Leverenz, W McCormick, ... Journal of the American Geriatrics Society 47 (5), 564-569, 1999 | 538 | 1999 |
| Pathological correlates of dementia in a longitudinal, population‐based sample of aging JA Sonnen, EB Larson, PK Crane, S Haneuse, G Li, GD Schellenberg, ... Annals of neurology 62 (4), 406-413, 2007 | 501 | 2007 |
| Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study O Sabri, MN Sabbagh, J Seibyl, H Barthel, H Akatsu, Y Ouchi, K Senda, ... Alzheimer's & dementia 11 (8), 964-974, 2015 | 493 | 2015 |
| Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression M Shi, J Bradner, AM Hancock, KA Chung, JF Quinn, ER Peskind, ... Annals of neurology 69 (3), 570-580, 2011 | 474 | 2011 |
| Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-ε4 allele DG Cook, JB Leverenz, PJ McMillan, JJ Kulstad, S Ericksen, RA Roth, ... The American journal of pathology 162 (1), 313-319, 2003 | 470 | 2003 |
| Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders F Abdi, JF Quinn, J Jankovic, M McIntosh, JB Leverenz, E Peskind, ... Journal of Alzheimer's Disease 9 (3), 293-348, 2006 | 468 | 2006 |
| Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases H Nakashima-Yasuda, K Uryu, J Robinson, SX Xie, H Hurtig, JE Duda, ... Acta neuropathologica 114, 221-229, 2007 | 463 | 2007 |
